Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy.

Bauman, Glenn S; Corkum, Mark T; Fakir, Hatim; Nguyen, Timothy K; Palma, David A

Bauman, Glenn S; Corkum, Mark T; Fakir, Hatim; Nguyen, Timothy K; Palma, David A.

Afiliación

Bauman GS; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre, 790 Commissioners Rd. E, London, Ontario, N6C 1K1, Canada. Glenn.bauman@lhsc.on.ca.
Corkum MT; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre, 790 Commissioners Rd. E, London, Ontario, N6C 1K1, Canada.
Fakir H; Department of Medical Biophysics, London Health Sciences Centre, London, Ontario, Canada.
Nguyen TK; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre, 790 Commissioners Rd. E, London, Ontario, N6C 1K1, Canada.
Palma DA; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre, 790 Commissioners Rd. E, London, Ontario, N6C 1K1, Canada.

BMC Cancer ; 21(1): 405, 2021 Apr 14.

Article en En | MEDLINE | ID: mdl-33853550

Asunto(s)

Protocolos Clínicos; Neoplasias/patología; Neoplasias/radioterapia; Radiocirugia/métodos; Fraccionamiento de la Dosis de Radiación; Humanos; Metástasis de la Neoplasia; Estadificación de Neoplasias; Radiocirugia/efectos adversos; Dosificación Radioterapéutica; Proyectos de Investigación

Palabras clave

Cancer; Clinical trial (phase I); Metastatic disease; Stereotactic radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos Clínicos / Radiocirugia / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google